Hypoglycemia possibly caused by CYP2C9-mediated drug interaction in combination with bucolome: a case report

BACKGROUND: Bucolome is a non-steroidal anti-inflammatory drug and uricosuric agent, currently used only in Japan. It is known to induce drug interactions by inhibiting cytochrome P450 (CYP) 2C9. It is often used to enhance the anticoagulant effect of warfarin by utilizing its drug interactions. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Tateishi, Hiroki, Miyazu, Daisuke, Kurinami, Miho, Ieiri, Ichiro, Hirakawa, Masaaki, Watanabe, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564963/
https://www.ncbi.nlm.nih.gov/pubmed/34727989
http://dx.doi.org/10.1186/s40780-021-00221-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564963/
https://www.ncbi.nlm.nih.gov/pubmed/34727989
http://dx.doi.org/10.1186/s40780-021-00221-y

Ejemplares similares